HK1044758A1 - Protease inhibitors - Google Patents

Protease inhibitors

Info

Publication number
HK1044758A1
HK1044758A1 HK02104641.3A HK02104641A HK1044758A1 HK 1044758 A1 HK1044758 A1 HK 1044758A1 HK 02104641 A HK02104641 A HK 02104641A HK 1044758 A1 HK1044758 A1 HK 1044758A1
Authority
HK
Hong Kong
Prior art keywords
protease inhibitors
protease
inhibitors
Prior art date
Application number
HK02104641.3A
Other languages
Chinese (zh)
Inventor
S Yamashita Dennis
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of HK1044758A1 publication Critical patent/HK1044758A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/12—Eight-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK02104641.3A 1999-03-31 2002-06-21 Protease inhibitors HK1044758A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12725099P 1999-03-31 1999-03-31
PCT/US2000/008833 WO2000058296A1 (en) 1999-03-31 2000-03-31 Protease inhibitors

Publications (1)

Publication Number Publication Date
HK1044758A1 true HK1044758A1 (en) 2002-11-01

Family

ID=22429122

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02104641.3A HK1044758A1 (en) 1999-03-31 2002-06-21 Protease inhibitors

Country Status (8)

Country Link
EP (1) EP1173429A4 (en)
JP (1) JP2002540199A (en)
AU (1) AU4066900A (en)
CO (1) CO5180536A1 (en)
HK (1) HK1044758A1 (en)
PE (1) PE20001607A1 (en)
UY (1) UY26088A1 (en)
WO (1) WO2000058296A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
WO2001034599A1 (en) 1999-11-10 2001-05-17 Smithkline Beecham Corporation Protease inhibitors
AU1474801A (en) 1999-11-10 2001-06-06 Smithkline Beecham Corporation Protease inhibitors
JP2003513972A (en) 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション Protease inhibitor
CN1416346A (en) 2000-03-21 2003-05-07 史密丝克莱恩比彻姆公司 Peotease inhibitors
US7282512B2 (en) 2002-01-17 2007-10-16 Smithkline Beecham Corporation Cycloalkyl ketoamides derivatives useful as cathepsin K inhibitors
JP2004196696A (en) * 2002-12-18 2004-07-15 Kyowa Hakko Kogyo Co Ltd Arthritis-preventing or treating agent
CN113651795B (en) * 2021-09-14 2022-09-02 江西开源香料有限公司 Synthesis method of watermelon ketone

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374623A (en) * 1992-08-20 1994-12-20 Prototek, Inc. Cysteine protease inhibitors effective for in vivo use

Also Published As

Publication number Publication date
AU4066900A (en) 2000-10-16
CO5180536A1 (en) 2002-07-30
UY26088A1 (en) 2000-10-31
JP2002540199A (en) 2002-11-26
WO2000058296A1 (en) 2000-10-05
EP1173429A4 (en) 2002-06-19
EP1173429A1 (en) 2002-01-23
PE20001607A1 (en) 2001-03-07

Similar Documents

Publication Publication Date Title
PL349192A1 (en) Protease inhibitors
GB9912961D0 (en) Metalloprotease inhibitors
AU4344101A (en) Protease inhibitors
EP1093367A4 (en) Protease inhibitors
IL145085A0 (en) Dihetero-substituted metalloprotease inhibitors
EP1067894A4 (en) Protease inhibitors
EP1235577A4 (en) Protease inhibitors
EP1079821A4 (en) Protease inhibitors
IL153421A0 (en) Protease inhibitors
EP1232155A4 (en) Protease inhibitors
EP1231921A4 (en) Protease inhibitors
EP1229915A4 (en) Protease inhibitors
EP1229914A4 (en) Protease inhibitors
EP1229912A4 (en) Protease inhibitors
HK1041690A1 (en) Protease inhibitors
EP1086083A4 (en) Protease inhibitors
IL151087A0 (en) Protease inhibitors
EP1173429A4 (en) Protease inhibitors
HK1043534A1 (en) Protease inhibitors
EP1233771A4 (en) Protease inhibitors
EP1351930A4 (en) Protease inhibitors
EP1229911A4 (en) Protease inhibitors
EP1231923A4 (en) Protease inhibitors
EP1231922A4 (en) Protease inhibitors
EP1232154A4 (en) Protease inhibitors